KATIE SNELL: Open Payments
NPI 1184863987 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 8 payments from 8 companies in 2025. Trend: 2023 $238 · 2024 $39 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $33 |
| SOBI, INC | 1 | $30 |
| GENZYME CORPORATION | 1 | $30 |
| Karyopharm Therapeutics Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $23 |
| BeOne Medicines USA, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Trodelvy, Vyloy, Vonjo, SARCLISA, XPOVIO, VENCLEXTA, TEVIMBRA, KEYTRUDA QLEX.
Industry payments across CO — which companies pay providers there.
